Alexandre Hirayama
@xanhira
Followers
113
Following
289
Statuses
50
MD, Assistant Professor @fredhutch and @UWMedicine
Seattle, WA
Joined January 2010
RT @Hemasphere_EHA: In the management of relapsed/refractory large B-cell lymphoma (LBCL) , the tumor microenvironment (TME) is a key and u…
0
1
0
RT @drjgauthier: Dr. Hirayama @xanhira discussing secondary malignancies after CAR T-cell therapy at our Seattle Cellular Therapy Summit @b…
0
10
0
Timing of Anti-PD-L1 Antibody Initiation Affects Efficacy/Toxicity of CD19 CAR-T Cell Therapy for Large B-Cell Lymphoma @fredhutch, @ekimblepl, @drjgauthier, @NGazeau14, @mshadman
0
5
16
RT @fredhutch: This year has been one of significant change for Fred Hutchinson Cancer Center. Take a look back at some of the most compell…
0
4
0
RT @fredhutch: More abstracts tonight from @NGazeau14, @xanhira, @drjgauthier and many other Fred Hutch physicians and researchers. Come sa…
0
6
0
RT @fredhutch: Day two of #ASH22 poster sessions feature presentations by Drs. @xanhira, Ryan Lynch, Molly Tokaz and Stefan Radtke. Learn m…
0
3
0
0
5
0
RT @drjgauthier: #ASH22 Abstract #3316 Timing of PD-L1 Blockade with Durvalumab May Affect Outcomes of CD19 CAR-T Cell Therapy for Relapse…
0
2
0
RT @drjgauthier: Short 🧵highlighting CAR T-cell therapy research from our group @fredhutch @UW soon to be presented at #ASH22 in New Orlean…
0
17
0
RT @HemOncToday: 🎙“We are waiting for a commercial #CARTcell option for patients with chronic lymphocytic leukemia, especially for those wh…
0
1
0
RT @GoHealio: Minimal residual disease negativity key to durable remissions after CAR-T #CellTherapy for chronic lymphocytic leukemia https…
0
1
0
RT @drjgauthier: A fantastic opportunity to join our group @fredhutch @EvNewell1 as a Bioinformatics Analyst. You w…
0
6
0
RT @NektarNews: At #ASH21, we presented data for NKTR-255 in patients with hematologic malignancies, including patients with prior CAR-T Th…
0
1
0
RT @drjgauthier: Press release @bmsnews - Positive Topline Results from Phase 3 TRANSFORM Trial Evaluating Breyanzi (lisocabtagene marale…
0
6
0
RT @RahulBanerjeeMD: ⬇️ Come talk about late AEs from CAR-T, post-CAR-T vaccines, CAR-T survivorship care plans, and more! Excited to part…
0
5
0
RT @drjgauthier: Our new paper on second infusions of CD19 CAR T-cells is finally out *in print* in @BloodJournal !
0
131
0